Premium Lenalidomide API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Lenalidomide (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Immunomodulatory Imide Drug (IMiD) / Antineoplastic Agent

Indications: Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Mantle Cell Lymphoma (MCL)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Lenalidomide distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Lenalidomide is a highly potent, orally active small-molecule Active Pharmaceutical Ingredient (API). In hematological oncology, it is classified as an immunomodulatory imide drug (IMiD) and is a structural derivative of thalidomide. For pharmaceutical manufacturers expanding their oncology portfolios, this API is an essential component for therapies targeting severe blood cancers.

The pharmacological profile of Lenalidomide is multifaceted, acting directly on the bone marrow microenvironment. At the cellular and molecular level, the API functions by binding to cereblon (CRBN), a component of the cullin-RING E3 ubiquitin ligase complex. This binding alters the substrate specificity of the complex, leading to the ubiquitination and degradation of specific transcription factors (Ikaros and Aiolos) that are vital for the survival of malignant lymphoid cells.

By facilitating this targeted degradation, Lenalidomide induces apoptosis (programmed cell death) in abnormal tumor cells within the bone marrow while simultaneously stimulating the proliferation of normal, healthy blood cells. Furthermore, it exhibits potent anti-angiogenic properties, inhibiting the formation of new blood vessels that tumors rely on for growth, and alters cytokine production by inhibiting tumor necrosis factor-alpha (TNF-α) and stimulating interleukin-2 (IL-2).

For formulation scientists, integrating this API enables the development of highly effective oral oncology therapeutics. In commercial manufacturing, this active ingredient is typically formulated into hard gelatin capsules in varying strengths.

Sourcing Lenalidomide in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced hematological oncology formulations requires a highly secure, traceable, and resilient raw material pipeline. Procuring high-potency active pharmaceutical ingredients (HPAPIs) for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing LENALIDOMIDE Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you are conducting pilot batches or executing a high-volume LENALIDOMIDE api Pakistan procurement order, we help ensure that your commercial batch schedules are met without costly line stoppages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during geometric dilution and capsule filling processes.

Technical Specifications for QA & R&D

The Lenalidomide API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards (USP/EP).

• Chemical Name: 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
• CAS Number: 191732-72-6
• Appearance: Off-white to pale-yellow solid powder
• Molecular Formula: C13H13N3O3
• Molecular Weight: 259.26 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Very slightly soluble in water; soluble in specific organic solvents. Detailed solubility parameters and polymorphic form data are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Lenalidomide is a High Potency Active Pharmaceutical Ingredient (HPAPI) and a known, severe human teratogen. Facilities processing this API must enforce the highest levels of occupational exposure limits (OEB 4/5) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, protected from excessive heat and ambient humidity) to prevent chemical degradation.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including powered air-purifying respirators (PAPR), double chemical-resistant nitrile gloves, and full protective facility suits. Weighing, dispensing, micronization, milling, and blending stages must be executed exclusively within negative-pressure containment isolators or high-containment glove boxes to prevent the inhalation of airborne particulates, dermal absorption, and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.